Not Yet Recruiting
Standard of Care Comparative Arm of Phase 1/2 Gene Therapy Trial DREPAMIR" in Severe Sickle Cell Disease Patients
NCT07752043
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +9 more
- Locations
-
- Necker-Enfants Malades Hospital, Apheresis Unit Paris, Île-de-France Region, France